Quest Diagnostics Net Worth 2010-2023 | DGX

Interactive chart of historical net worth (market cap) for Quest Diagnostics (DGX) over the last 10 years. How much a company is worth is typically represented by its market capitalization, or the current stock price multiplied by the number of shares outstanding. Quest Diagnostics net worth as of April 23, 2024 is $14.45B.
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $14.447B $9.252B
Quest Diagnostics, Inc. is the provider of commercial laboratory services. Quest provides lab testing services to physicians, hospitals, managed care organizations, employers, government institutions and other clinical laboratories. The company consists of 2 business groups - Diagnostic Information Services and Diagnostic Solutions. The company's focus is on two elements - to accelerate growth and to drive operational excellence. Restore Growth: The company has adopted seven tactical approaches to accelerate growth such as sales and marketing; development of esoteric testing through a disease focus; partnerships with hospitals and successful testing of international IDNs; creation of value from information assets; leadership in companion diagnostics; extension into adjacent markets. Drive Operational excellence: The company plans to focus on four strategic requirements - to enhance end-to-end customer value chain, enterprise information technology architecture, business performance tools and cost excellence.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $16.532B 10.00
DaVita (DVA) United States $11.622B 15.81
Chemed (CHE) United States $9.137B 28.75
Encompass Health (EHC) United States $8.044B 22.07
Elanco Animal Health (ELAN) United States $6.389B 14.53
Option Care Health (OPCH) United States $5.286B 20.69
RadNet (RDNT) United States $3.263B 95.30
Amedisys (AMED) United States $2.981B 21.27
LifeStance Health (LFST) United States $2.235B 0.00
Astrana Health (ASTH) United States $2.075B 26.17
Addus HomeCare (ADUS) United States $1.517B 23.26
U.S Physical Therapy (USPH) United States $1.506B 39.03
Pennant (PNTG) United States $0.626B 36.58
Aveanna Healthcare Holdings (AVAH) United States $0.437B 0.00
Atai Life Sciences (ATAI) Germany $0.310B 0.00
Daxor (DXR) United States $0.046B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.030B 0.00
ATI Physical Therapy (ATIP) United States $0.017B 0.00
Psychemedics (PMD) United States $0.015B 0.00
Novo Integrated Sciences (NVOS) United States $0.010B 0.00
Ontrak (OTRK) United States $0.008B 0.00
IMAC Holdings (BACK) United States $0.004B 0.00